Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) EBIT: 2021-2025

Historic EBIT for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$57.4 million.

  • Core Scientific's EBIT fell 39.32% to -$57.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$166.1 million, marking a year-over-year decrease of 777.33%. This contributed to the annual value of -$19.2 million for FY2024, which is 314.22% down from last year.
  • Per Core Scientific's latest filing, its EBIT stood at -$57.4 million for Q3 2025, which was down 118.48% from -$26.3 million recorded in Q2 2025.
  • Core Scientific's EBIT's 5-year high stood at $102.2 million during Q4 2021, with a 5-year trough of -$1.0 billion in Q2 2022.
  • Over the past 3 years, Core Scientific's median EBIT value was -$12.0 million (recorded in 2023), while the average stood at -$12.4 million.
  • Per our database at Business Quant, Core Scientific's EBIT crashed by 8,489.92% in 2022 and then surged by 626.48% in 2024.
  • Core Scientific's EBIT (Quarterly) stood at $102.2 million in 2021, then slumped by 722.64% to -$636.1 million in 2022, then spiked by 100.62% to $3.9 million in 2023, then tumbled by 1,111.26% to -$39.8 million in 2024, then plummeted by 39.32% to -$57.4 million in 2025.
  • Its EBIT was -$57.4 million in Q3 2025, compared to -$26.3 million in Q2 2025 and -$42.6 million in Q1 2025.